FDA wants stronger warning labels for long-acting opioids
April 17, 2014 at 13:08 PM EDT
April 17 (Reuters) - The U.S. Food and Drug Administration is requiring labels of all long-acting opioids to say they should be used strictly for patients in severe pain, a response to surging overdoses and deaths each year from the widely used pain medicines.